These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35978674)

  • 21. [Severe acute respiratory syndrome coronavirus 2 infection in renal transplant recipients: A case report].
    Li QY; Cheng Q; Zhao ZL; Dai NN; Zeng L; Zhu L; Guo W; Li C; Wang JH; Li S; Ge QG; Shen N
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 52(4):780-784. PubMed ID: 32773818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical course of SARS-CoV-2 infection and recovery in lung transplant recipients.
    Trindade AJ; Chapin KC; Gannon WD; Hoy H; Demarest CT; Lambright ES; McPherson KA; Norfolk SG; Robbins IM; Bacchetta M; Erasmus DB; Shaver CM
    Transpl Infect Dis; 2022 Dec; 24(6):e13967. PubMed ID: 36271645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
    Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
    Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
    Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
    Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Venous thrombosis, thromboembolism, biomarkers of inflammation, and coagulation in coronavirus disease 2019.
    Thondapu V; Montes D; Rosovsky R; Dua A; McDermott S; Lu MT; Ghoshhajra B; Hoffmann U; Gerhard-Herman MD; Hedgire S
    J Vasc Surg Venous Lymphat Disord; 2021 Jul; 9(4):835-844.e4. PubMed ID: 33188961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 Infection in Kidney Transplant Recipients: A Single-Center Case Series of 22 Cases From Belgium.
    Devresse A; Belkhir L; Vo B; Ghaye B; Scohy A; Kabamba B; Goffin E; De Greef J; Mourad M; De Meyer M; Yombi JC; Kanaan N
    Kidney Med; 2020; 2(4):459-466. PubMed ID: 32775986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. When is it safe to perform abdominal transplantation in patients with prior SARS-CoV-2 infection: A case series.
    Natori Y; Anjan S; Martin EF; Selvagi G; Villavicencio A; Coro A; Mendez-Castaner LA; Mattiazzi A; Pagan J; Ortigosa-Goggins M; Roth D; Kupin W; O'Brien CB; Arosemena LR; Ciancio G; Burke GW; Morsi M; Figueiro JM; Chen L; Tekin A; Miyashiro R; Simkins J; Abbo LM; Vianna RM; Guerra G
    Clin Transplant; 2021 Dec; 35(12):e14370. PubMed ID: 34032328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).
    Ye Q; Wang H; Xia X; Zhou C; Liu Z; Xia ZE; Zhang Z; Zhao Y; Yehenala J; Wang S; Zhou G; Hu K; Wu B; Wu CT; Wang S; He Y
    Trials; 2020 Jun; 21(1):520. PubMed ID: 32532356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: a United States cohort study.
    Pierce-Williams RAM; Burd J; Felder L; Khoury R; Bernstein PS; Avila K; Penfield CA; Roman AS; DeBolt CA; Stone JL; Bianco A; Kern-Goldberger AR; Hirshberg A; Srinivas SK; Jayakumaran JS; Brandt JS; Anastasio H; Birsner M; O'Brien DS; Sedev HM; Dolin CD; Schnettler WT; Suhag A; Ahluwalia S; Navathe RS; Khalifeh A; Anderson K; Berghella V
    Am J Obstet Gynecol MFM; 2020 Aug; 2(3):100134. PubMed ID: 32391519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Inflammatory Biomarkers with Immunosuppression Management and Outcomes in Kidney Transplant Recipients with COVID-19.
    AbdulRahim N; McAdams M; Xu P; Wojciechowski D; La Hoz RM; Lu C; Vazquez MA; Hedayati SS
    Transplant Proc; 2021 Oct; 53(8):2451-2467. PubMed ID: 34465422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The case of a liver-transplant recipient with severe acute respiratory syndrome coronavirus 2 infection who had a favorable outcome.
    Hayashi K; Ito Y; Yamane R; Yoshizaki M; Matsushita K; Kajikawa G; Kozawa T; Mizutani T; Shimizu Y; Nagano K; Tachi K; Yoshioka K; Goto H
    Clin J Gastroenterol; 2021 Jun; 14(3):842-845. PubMed ID: 33675512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver Injury in Liver Transplant Recipients With Coronavirus Disease 2019 (COVID-19): U.S. Multicenter Experience.
    Rabiee A; Sadowski B; Adeniji N; Perumalswami PV; Nguyen V; Moghe A; Latt NL; Kumar S; Aloman C; Catana AM; Bloom PP; Chavin KD; Carr RM; Dunn W; Chen VL; Aby ES; Debes JD; Dhanasekaran R;
    Hepatology; 2020 Dec; 72(6):1900-1911. PubMed ID: 32964510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronavirus Disease 2019 in Solid Organ Transplant: A Multicenter Cohort Study.
    Kates OS; Haydel BM; Florman SS; Rana MM; Chaudhry ZS; Ramesh MS; Safa K; Kotton CN; Blumberg EA; Besharatian BD; Tanna SD; Ison MG; Malinis M; Azar MM; Rakita RM; Morilla JA; Majeed A; Sait AS; Spaggiari M; Hemmige V; Mehta SA; Neumann H; Badami A; Goldman JD; Lala A; Hemmersbach-Miller M; McCort ME; Bajrovic V; Ortiz-Bautista C; Friedman-Moraco R; Sehgal S; Lease ED; Fisher CE; Limaye AP;
    Clin Infect Dis; 2021 Dec; 73(11):e4090-e4099. PubMed ID: 32766815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of COVID-19 on the liver: The experience of a single center.
    Liakina V; Stundiene I; Milaknyte G; Bytautiene R; Reivytyte R; Puronaite R; Urbanoviciute G; Kazenaite E
    World J Gastroenterol; 2022 Oct; 28(39):5735-5749. PubMed ID: 36338891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of COVID-19 in solid organ transplant recipients: A matched cohort study.
    Pereira MR; Arcasoy S; Farr MA; Mohan S; Emond JC; Tsapepas DS; Shi Q; Purpura L; Uhlemann AC; Zucker J; Verna EC
    Transpl Infect Dis; 2021 Aug; 23(4):e13637. PubMed ID: 33993630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
    Barco S; Bingisser R; Colucci G; Frenk A; Gerber B; Held U; Mach F; Mazzolai L; Righini M; Rosemann T; Sebastian T; Spescha R; Stortecky S; Windecker S; Kucher N
    Trials; 2020 Sep; 21(1):770. PubMed ID: 32907635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severity of COVID-19 among solid organ transplant recipients in Canada, 2020-2021: a prospective, multicentre cohort study.
    Hall VG; Solera JT; Al-Alahmadi G; Marinelli T; Cardinal H; Poirier C; Huard G; Prasad GVR; De Serres SA; Isaac D; Mainra R; Lamarche C; Sapir-Pichhadze R; Gilmour S; Humar A; Kumar D
    CMAJ; 2022 Aug; 194(33):E1155-E1163. PubMed ID: 36302101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Presentation, Treatment, and Mortality Rate in Liver Transplant Recipients With Coronavirus Disease 2019: A Systematic Review and Quantitative Analysis.
    Fraser J; Mousley J; Testro A; Smibert OC; Koshy AN
    Transplant Proc; 2020 Nov; 52(9):2676-2683. PubMed ID: 32891405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.